With NIH “Accountability” As Background, Advocates Support Budget Increases.
Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.
Bush Nominates VA Official For HHS Deputy Secretary.
Stronger Anti-Smoking Efforts Needed For Women, SG Says.
Meharry, Vanderbilt Win Grant For Research Collaboration.
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
Firm Begins Phase II Trial Of LDP-341 For Myeloma.
Faulding, NaPro In Agreement For Marketing Paclitaxel.
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”